Mandibular Advancement Device on Sleep Quality in Obstructive Sleep Apnea Patients
DAMOSA
Impact of Treatment With Mandibular Advancement Device (MAD) on Sleep Quality in Patients With Obstructive Sleep Apnea (OSA)
1 other identifier
observational
50
1 country
1
Brief Summary
Sleep is an important factor that influences long-term quality of life with known health consequences. Obstructive sleep apnea, the most prevalent disease that disturbs sleep, is considered a public health problem. Treatment with continuous positive airway pressure is cost effective and reverses the clinical consequences but there is a percentage of patients who do not tolerate it or leave it without treatment and with potential future health complications. Mandibular advancement device can be a valid and well tolerated alternative, it is known that it reduces apnea-hypopnea index, but its effect on the improvement of sleep quality is evaluated by polysomnography that interferes with the quality of sleep. There is an ambulatory monitoring device for sleep quality and circadian rhythms, which can register prolonged periods of time, under natural conditions and at a lower cost than a polysomnography. This pilot project assesses whether mandibular advancement device is an effective and well tolerated alternative in the treatment of obstructive sleep apnea to improve the quality of life and sleep in the medium and long term.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
January 30, 2023
CompletedFirst Posted
Study publicly available on registry
December 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedDecember 13, 2023
December 1, 2023
1.7 years
January 30, 2023
December 5, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
mandibular advancement device on sleep quality
Tolerability and efficacy of treatment with a mandibular advancement device (MAD) on sleep quality in patients with Obstructive Sleep Apnea (OSA) measured by the ambulatory circadian monitoring device.
3 years
ambulatory circadian monitoring device
To evaluate improvement in sleep quality with mandibular advancement devices measured by fragmentation and stability of sleep by the circadian monitoring sensor.
3 years
home sleep apnea test
To evaluate the number of residual apneic breaths measured by home home sleep apnea test
3 years
Secondary Outcomes (4)
Obstructive sleep apnea severity
3 years
questionnaire SF-12
3 years
questionnaire EuroQoL
3 years
questionnaire iPAQ
3 years
Interventions
The multidisciplinary sleep unit assessment and follow-up protocol will be followed for this group of patients based on the Spanish Clinical Practice Guideline of the Spanish Sleep Society (SES) on the use of mandibular advancement devices in the treatment of patients with obstructive sleep apnea
Eligibility Criteria
Patients who come to the Multidisciplinary sleep unit of the Fundación Jiménez Díaz with suspicion of Obstructive sleep apnea and who present an Apnea Hypopnea Index greater than five
You may qualify if:
- Diagnosis of Obstructive Sleep Apnea Syndrome
- opt for mandibular advancement device as 1st treatment alternative
- opt for mandibular advancement device due to intolerance to continuous positive airway pressure
You may not qualify if:
- Patient with orthodontics, malocclusion and periodontal or temporomandibular joint disease who, after assessment by dentistry contraindicates it.
- Central Sleep apnea (more than 50% of central events in the baseline polygraph).
- Under 18 years old.
- Pregnancy
- Comorbidities that can potentially alter sleep architecture.
- Psychophysical inability to complete questionnaires.
- Not obtaining informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maria Fernanda Troncoso Acevedo
Madrid, 28004, Spain
Biospecimen
blood
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigador principal
Study Record Dates
First Submitted
January 30, 2023
First Posted
December 13, 2023
Study Start
January 1, 2021
Primary Completion
September 30, 2022
Study Completion
December 31, 2024
Last Updated
December 13, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share